DMT

As interest in psychedelic medicine grows, researchers are increasingly turning to natural substances like ayahuasca to explore their potential in treating mental health disorders. A recent review by researchers at the University of São Paulo sheds light on how ayahuasca – a traditional...

DMT, or dimethyltryptamine, has intrigued researchers and psychedelic enthusiasts for its profound effects on consciousness. Known for inducing otherworldly visions, from “machine elves” to mystical figures, some scientists now propose that DMT may play a key role in extraordinary...

Atai Life Sciences (NASDAQ:ATAI), a clinical-stage biopharmaceutical company focused on mental health innovation, announced its third-quarter 2024 financial results Wednesday as well as updates on its clinical and corporate strategies. With notable advancements in its investigational programs, the...

In an unexpected turn, some elite golfers are trading traditional pharmaceuticals for psychedelics like psilocybin and ayahuasca, hoping to gain a mental edge. As Double Blind reported, while both compounds are associated with altered states, they're increasingly being used in microdoses by golfers...

A recent study published in the Journal of Psychopharmacology sheds new light on how DMT, a powerful psychedelic, could impact both mental and physical well-being. The study found that profound, mystical experiences often reported by DMT users are closely linked to specific patterns of heart...

The U.S. Food and Drug Administration (FDA) has issued a complete response letter for MDMA-assisted psychotherapy (MDMA-AT) for treating post-traumatic stress disorder (PTSD) in which it calls for an additional phase 3 trial to further evaluate its safety and efficacy. As Psychiatric Times...

Irish psychedelic biotech firm GH Research PLC (NASDAQ:GHRS) reported its financial results for the second quarter ended June 30, 2024. Q2 2024 Financial Highlights Cash, cash equivalents, other financial assets and marketable securities were $204.5 million as of June 30, 2024, compared to cash,...

Psychedelics biotech Enveric Biosciences (NASDAQ:ENVB) announced positive preclinical results of its EB-003 drug candidate to be delivered via oral administration. EB-003 is a new, neuroplastogenic molecule designed to treat serious mental health disorders without the hallucinogenic effect...

Dave Hodges, founder of Zide Door in Oakland and the Church of Ambrosia in San Francisco, is leading a growing movement that challenges traditional boundaries between spiritual freedom, alternative therapies and the use of psychoactive substances. As federal prohibition continues to regulate...

The ongoing collaboration between SciSparc Ltd. (NASDAQ:SPRC) and Clearmind Medicine Inc. (NASDAQ:CMND) (CSE:CMND) (FSE: CWY) resulted in the Tuesday filing of three patent applications under the International Patent Cooperation Treaty. SciSparc, a specialty clinical-stage pharmaceutical company...

The Drug Enforcement Administration (DEA) is proposing the production of higher amounts of THC, psilocybin and DMR for research in 2024. In a notice scheduled to be published in the Federal Register on Wednesday, the agency said it is raising the proposed amounts as a response to a...

Studies and reports from the U.S. Department of Veterans Affairs (VA) and other research publications suggest that an estimated 20-30% of U.S. veterans may experience some form of mental health disorder, with depression and anxiety ranking high amongst conditions.  According the New England...

This article was originally published on Psychedelic Spotlight and appears here with permission. For the most part, psychedelics are still illegal in Mexico with a few exceptions. As Mexico’s lawmakers continue to express their interest in legalizing magic mushrooms, more questions about...

Small Pharma Inc. (OTCQB: DMTTF), the short-acting psychedelics biotech about to be purchased by Cybin Inc. (NYSE: CYBN), published its interim financial results for Q2 ended August 31, 2023.  Numbers showed: Cash of $5.6 (CA$7.68) million by August 31, vs. $13.5 million held by Feb. 28...

This article was originally published on Psychedelic Spotlight and appears here with permission. A new study published in PLOS One has presented results comparing the transformative effects on individuals' beliefs about death resulting from both near-death experiences and psychedelic trips....